Works matching Antisense nucleic acids


Results: 710
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

    Published in:
    British Journal of Cancer, 2013, v. 109, n. 10, p. 2579, doi. 10.1038/bjc.2013.619
    By:
    • Bianchini, D;
    • Omlin, A;
    • Pezaro, C;
    • Lorente, D;
    • Ferraldeschi, R;
    • Mukherji, D;
    • Crespo, M;
    • Figueiredo, I;
    • Miranda, S;
    • Riisnaes, R;
    • Zivi, A;
    • Buchbinder, A;
    • Rathkopf, D E;
    • Attard, G;
    • Scher, H I;
    • de Bono, J;
    • Danila, D C
    Publication type:
    Article
    23
    24
    25

    RNA Silencing in the Struggle against Disease.

    Published in:
    Annals of the New York Academy of Sciences, 2006, v. 1082, n. 1, p. 44, doi. 10.1196/annals.1348.051
    By:
    • PATZEL, VOLKER;
    • DIETRICH, ISABELL;
    • KAUFMANN, STEFAN H.E.
    Publication type:
    Article
    26

    Selected strategies to fight pathogenic bacteria.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2155816
    By:
    • Plotniece, Aiva;
    • Sobolev, Arkadij;
    • Supuran, Claudiu T.;
    • Carta, Fabrizio;
    • Björkling, Fredrik;
    • Franzyk, Henrik;
    • Yli-Kauhaluoma, Jari;
    • Augustyns, Koen;
    • Cos, Paul;
    • De Vooght, Linda;
    • Govaerts, Matthias;
    • Aizawa, Juliana;
    • Tammela, Päivi;
    • Žalubovskis, Raivis
    Publication type:
    Article
    27
    28

    An intranasal ASO therapeutic targeting SARS-CoV-2.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32216-0
    By:
    • Zhu, Chi;
    • Lee, Justin Y.;
    • Woo, Jia Z.;
    • Xu, Lei;
    • Nguyenla, Xammy;
    • Yamashiro, Livia H.;
    • Ji, Fei;
    • Biering, Scott B.;
    • Van Dis, Erik;
    • Gonzalez, Federico;
    • Fox, Douglas;
    • Wehri, Eddie;
    • Rustagi, Arjun;
    • Pinsky, Benjamin A.;
    • Schaletzky, Julia;
    • Blish, Catherine A.;
    • Chiu, Charles;
    • Harris, Eva;
    • Sadreyev, Ruslan I.;
    • Stanley, Sarah
    Publication type:
    Article
    29

    Antisense therapeutics.

    Published in:
    Nature Biotechnology, 1999, v. 17, n. 4, p. 403, doi. 10.1038/7973
    By:
    • Persidis, Aris
    Publication type:
    Article
    30
    31
    32
    34
    36
    37
    38
    39
    40
    41

    Marriage of convenience.

    Published in:
    Nature, 1993, v. 365, n. 6446, p. 490, doi. 10.1038/365490a0
    By:
    • Patel, Dinshaw J.
    Publication type:
    Article
    42
    43
    44

    Preclinical development of a miR-132 inhibitor for heart failure treatment.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14349-2
    By:
    • Foinquinos, Ariana;
    • Batkai, Sandor;
    • Genschel, Celina;
    • Viereck, Janika;
    • Rump, Steffen;
    • Gyöngyösi, Mariann;
    • Traxler, Denise;
    • Riesenhuber, Martin;
    • Spannbauer, Andreas;
    • Lukovic, Dominika;
    • Weber, Natalie;
    • Zlabinger, Katrin;
    • Hašimbegović, Ena;
    • Winkler, Johannes;
    • Fiedler, Jan;
    • Dangwal, Seema;
    • Fischer, Martin;
    • Roche, Jeanne de la;
    • Wojciechowski, Daniel;
    • Kraft, Theresia
    Publication type:
    Article
    45
    46
    47
    48
    49
    50